The current generation of sequencers, which are mostly based on sequencing by synthesis using DNA polymerases, are remarkable in terms of sequencing throughput, accuracy, and low cost. However, many technical challenges remain to be overcome to achieve the quality of the genome sequence in terms of per-base accuracy, the contiguity of the assembly and complete phasing of haplotype for personalized medicine.
A research scientist at the University of California, San Diego has developed a method called “Barcoding Contiguity Replication” (BCR) and enabling microfluidic devices for replicating DNA molecules in segments which are hardwired with contiguity information without fragmentation of the original DNA molecules. The technology enables the de novo assembly of both strands of entire individual DNA molecules or chromosomes with 100% contiguity by simple lookup of the contiguity information physically built into the DNA segments in the replication process. Therefore, the invention will enable the de novo sequencing of genome and epigenome from single cells with full haplotype resolution and extremely high accuracy using any existing high-throughput sequencing technologies, including the current generation of short-read sequencing platforms and the emerging nanopore and other single-molecule sequencing platforms.
The invention applications include: DNA and genome sequencing for applications in genetic diagnostics, pathogen detections, biomedical and agriculture research, drug target identification, tailored personalized medical treatment and others.
Country | Type | Number | Dated | Case |
United States Of America | Issued Patent | 10,428,373 | 10/01/2019 | 2013-318 |
dna, rna, nucleic acid, genomics, genome, sequencer, haplotype, diagnostics, genetic, biomedical, targeted, drug